In addition, rapamycin significantly decreased the elevated expression of Col1A1, ANP and BNP induced by OSA-Exos treatments and alleviated OSA-Exos-induced cardiomyocyte injury. The gene discussed is COL1A1; the disease is obstructive sleep apnea syndrome.